Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in
// Your mission Eligo is building a pioneering platform technology that enables us to engineer phage-derived particles (Eligobiotics) to package and deliver modular therapeutic DNA payloads to genetically (re)program a wide range of bacterial species in situ.